Colestid Patent Expiration

Colestid is a drug owned by Pfizer Inc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Feb 13, 2013. Details of Colestid's patents and their expiration are given in the table below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5490987 Tableting of colestipol hydrochloride
Feb, 2013

(11 years ago)

Expired

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

US patents provide insights into the exclusivity only within the United States, but Colestid is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Colestid's family patents as well as insights into ongoing legal events on those patents.

Colestid's Family Patents


Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List


Generic Launch

Generic Release Date:

Colestid's generic launch date based on the expiry of its last outstanding patent is estimated to be Feb 13, 2013 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)

Colestid Generic API suppliers:

Colestipol Hydrochloride is the generic name for the brand Colestid. 4 different companies have already filed for the generic of Colestid, with Impax Labs having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Colestid's generic





About Colestid

Colestid is a drug owned by Pfizer Inc. Colestid uses Colestipol Hydrochloride as an active ingredient. Colestid was launched by Pfizer in 1994.

Approval Date:

Colestid was approved by FDA for market use on 19 July, 1994.

Active Ingredient:

Colestid uses Colestipol Hydrochloride as the active ingredient. Check out other Drugs and Companies using Colestipol Hydrochloride ingredient

Dosage:

Colestid is available in tablet form for oral use. Given below is detailed information on Dosage -

Strength Dosage Form Availability Application Pathway
1GM TABLET Prescription ORAL